DXB 0.00% 51.0¢ dimerix limited

Ann: Dimerix Presents at ASX Small & Mid-Cap Conference, page-35

  1. 30 Posts.
    lightbulb Created with Sketch. 1
    On slide #13, it has been mentioned that "DMX-200 is the only therapy in phase 3 development". However, a quick search showed that FILSPARI® (sparsentan) is also in phase 3. From one website, my understanding is it is for IgA nephropathy; however, another website mentioned FSGS, too. Can anyone shed some light on this?
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
51.0¢
Change
0.000(0.00%)
Mkt cap ! $280.6M
Open High Low Value Volume
51.5¢ 54.5¢ 51.0¢ $1.715M 3.301M

Buyers (Bids)

No. Vol. Price($)
7 365433 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
51.5¢ 19658 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.